Independent Study Validates Simplexa Dengue Test as Focus Diagnostics Expands Menu | GenomeWeb

NEW YORK (GenomeWeb) — An independent study by researchers in Indonesia has shown that Focus Diagnostics' Simplexa Dengue test has a higher detection rate than conventional RT-PCR or SYBR Green real-time RT-PCR methods in clinical samples. The Focus test, which simultaneously detects and serotypes dengue virus, could be used for future dengue surveillance studies, the authors concluded.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.